Financial Issues
The Latest
Indianapolis HIV Service Providers Persevere Amid Stigma and Lack of Funding
In conservative Central Indiana, this LGBTQ-run agency transcended its repressive origins and helps people with HIV who are discriminated against at other local institutions.
San Antonio Is Making Gains Toward Viral Suppression
Using a one-stop-shop model of care and wraparound services, this organization makes sure clients don't have to travel to multiple centers to get their needs met.
Planning for Retirement While Living With HIV
Whether you're on public assistance or you're more well off, there are things you can do to plan for a secure future.
I Moved to Atlanta Four Months Ago, and Getting Into HIV Care Was Hell
Spoken word artist Michael "Miss Mikey" Lamb shares his saga of fighting for health coverage -- and why people fall through the cracks.
How Activists Uncovered CDC's Ownership of Truvada PrEP Patents
The #PrEP4All campaign made the call for affordable pre-exposure prophylaxis a national news story.
If Nobody Slashes the Price of Truvada for PrEP, What Happens Next?
Activists and doctors say they're ready to go further if Gilead won't agree to -- or the U.S. government won't force -- a price reduction to make PrEP accessible to more Americans who need it.
Dovato Is a Newly Approved Two-Drug HIV Regimen. Do Fewer Drugs Mean a Lower-Cost HIV Treatment?
Advocates say the price is a step in the right direction. But does it go far enough?
Sticker Shock: PrEP Is Not Cost-Effective at Current Price, Health Economists Find
But a survey reveals that about a third of black and Latino gay men would be willing to pay more than $50 per month for a prescription.
Trump's Justice Department Just Declared All-Out War on Obamacare. What Does It Mean?
We answer some key questions about the latest new effort to kill the Affordable Care Act, including what it means for people living with HIV and what can do to make a difference.
PrEP Pricing Is the Elephant in the Room at the CDC National HIV Prevention Conference
In a debate during a plenary session, Michael Saag, M.D., argued for more activism to make PrEP accessible to people who need it.